(Reuters) -US Food and Drug Administration on Monday gave full approval to the COVID-19 vaccine from Pfizer Inc. and German partner BioNTech SE for use in people over 16 years of age.
The vaccine has been approved for emergency use since December, and more than 204 million people in the United States have received it, based on Sunday's data. However, none of the three authorized COVID-19 vaccines had previously received full FDA approval.
Public health officials hope it will convince more unvaccinated Americans that Pfizer's shots are safe and effective. The vaccine's hesitation among some Americans has hindered the US response to the new coronavirus.
"While millions of people have already safely received COVID-1
About 51% of Americans have been vaccinated completely so far, although a new influx of infections caused by the contagious Delta variant is ravaging parts of the country with low vaccination rates.